Seven Fleet Capital Management as of March 31, 2026
Portfolio Holdings for Seven Fleet Capital Management
Seven Fleet Capital Management holds 114 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology | 30.9 | $97M | 1.4M | 67.68 | |
| Tango Therapeutics (TNGX) | 3.3 | $11M | 502k | 20.92 | |
| Revolution Medicines (RVMD) | 2.5 | $7.9M | 81k | 97.25 | |
| Tyra Biosciences (TYRA) | 2.4 | $7.5M | 196k | 38.30 | |
| Liquidia Corporation Com New (LQDA) | 2.3 | $7.1M | 188k | 37.74 | |
| Agios Pharmaceuticals (AGIO) | 2.2 | $7.1M | 210k | 33.83 | |
| Century Therapeutics (IPSC) | 2.1 | $6.7M | 2.9M | 2.26 | |
| Enliven Therapeutics (ELVN) | 2.0 | $6.4M | 164k | 39.20 | |
| Vaxcyte (PCVX) | 2.0 | $6.3M | 109k | 58.11 | |
| Tango Therapeutics | 2.0 | $6.3M | 301k | 20.92 | |
| Cogent Biosciences (COGT) | 1.8 | $5.8M | 149k | 38.49 | |
| Avalo Therapeutics Com New | 1.7 | $5.4M | 360k | 14.93 | |
| Minerva Neurosciences Com New | 1.7 | $5.4M | 889k | 6.03 | |
| Cg Oncology (CGON) | 1.6 | $5.1M | 76k | 67.68 | |
| Pharvaris N V (PHVS) | 1.5 | $4.9M | 173k | 28.25 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.5 | $4.8M | 43k | 111.35 | |
| Dianthus Therapeutics (DNTH) | 1.4 | $4.6M | 54k | 83.92 | |
| Pharvaris N V | 1.3 | $4.1M | 144k | 28.25 | |
| Cytokinetics Com New (CYTK) | 1.3 | $4.0M | 61k | 65.91 | |
| Soleno Therapeutics (SLNO) | 1.2 | $3.9M | 116k | 33.48 | |
| Enliven Therapeutics | 1.2 | $3.7M | 95k | 39.20 | |
| Erasca (ERAS) | 1.1 | $3.6M | 223k | 16.18 | |
| Roivant Sciences SHS (ROIV) | 1.1 | $3.6M | 128k | 27.70 | |
| Cytomx Therapeutics | 1.1 | $3.4M | 714k | 4.70 | |
| Avalo Therapeutics Com New (AVTX) | 1.0 | $3.2M | 214k | 14.93 | |
| Eupraxia Pharmaceuticals (EPRX) | 1.0 | $3.1M | 434k | 7.24 | |
| Ideaya Biosciences (IDYA) | 0.9 | $2.9M | 86k | 33.32 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $2.8M | 626k | 4.47 | |
| Ascendis Pharma A/s Sponsored Ads (ASND) | 0.9 | $2.8M | 12k | 228.73 | |
| Compass Therapeutics (CMPX) | 0.9 | $2.7M | 517k | 5.29 | |
| Damora Therapeutics Com New (DMRA) | 0.8 | $2.6M | 101k | 25.90 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $2.6M | 129k | 20.13 | |
| Relay Therapeutics (RLAY) | 0.8 | $2.6M | 258k | 9.95 | |
| Axsome Therapeutics (AXSM) | 0.8 | $2.4M | 14k | 169.02 | |
| Compass Therapeutics | 0.7 | $2.2M | 424k | 5.29 | |
| Dianthus Therapeutics | 0.7 | $2.2M | 27k | 83.92 | |
| Eupraxia Pharmaceuticals | 0.6 | $2.0M | 276k | 7.24 | |
| Definium Therapeutics Com Shs (DFTX) | 0.6 | $1.9M | 100k | 18.90 | |
| Mineralys Therapeutics (MLYS) | 0.6 | $1.9M | 70k | 27.09 | |
| Soleno Therapeutics | 0.6 | $1.8M | 54k | 33.48 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $1.8M | 3.4k | 523.47 | |
| Cytomx Therapeutics (CTMX) | 0.6 | $1.7M | 371k | 4.70 | |
| Athira Pharma (LONA) | 0.5 | $1.7M | 165k | 10.28 | |
| Savara (SVRA) | 0.5 | $1.6M | 296k | 5.46 | |
| Perspective Therapeutics Com New (CATX) | 0.5 | $1.6M | 379k | 4.17 | |
| Assembly Biosciences Com New (ASMB) | 0.5 | $1.6M | 56k | 27.75 | |
| Sab Biotherapeutics Com New | 0.5 | $1.5M | 400k | 3.83 | |
| Minerva Neurosciences Com New (NERV) | 0.5 | $1.5M | 249k | 6.03 | |
| Zai Lab Adr (ZLAB) | 0.5 | $1.5M | 78k | 18.81 | |
| Tarsus Pharmaceuticals (TARS) | 0.4 | $1.4M | 20k | 70.15 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $1.2M | 83k | 14.63 | |
| Vaxcyte | 0.4 | $1.2M | 20k | 58.11 | |
| Arrivent Biopharma (AVBP) | 0.4 | $1.2M | 50k | 23.07 | |
| Larimar Therapeutics (LRMR) | 0.4 | $1.2M | 257k | 4.50 | |
| Krystal Biotech (KRYS) | 0.4 | $1.1M | 4.3k | 258.32 | |
| Inventiva Sa Ads (IVA) | 0.4 | $1.1M | 200k | 5.55 | |
| Lipocine Com New (LPCN) | 0.3 | $998k | 125k | 7.99 | |
| Spyre Therapeutics Com New (SYRE) | 0.3 | $993k | 20k | 50.44 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $976k | 103k | 9.52 | |
| Xencor (XNCR) | 0.3 | $965k | 80k | 12.06 | |
| Celldex Therapeutics Com New (CLDX) | 0.3 | $929k | 29k | 31.72 | |
| Replimune Group (REPL) | 0.3 | $921k | 120k | 7.65 | |
| Maze Therapeatics (MAZE) | 0.3 | $917k | 31k | 29.85 | |
| Eliem Therapeutics (CLYM) | 0.3 | $895k | 131k | 6.85 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $874k | 158k | 5.53 | |
| Alkermes SHS (ALKS) | 0.3 | $855k | 24k | 35.36 | |
| Silence Therapeutics Ads (SLN) | 0.3 | $826k | 157k | 5.27 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $805k | 86k | 9.39 | |
| Celcuity (CELC) | 0.2 | $685k | 6.0k | 114.14 | |
| An2 Therapeutics (ANTX) | 0.2 | $683k | 200k | 3.42 | |
| Denali Therapeutics (DNLI) | 0.2 | $678k | 35k | 19.20 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $669k | 1.1k | 592.98 | |
| Eli Lilly & Co. (LLY) | 0.2 | $662k | 720.00 | 919.77 | |
| Verastem Com New (VSTM) | 0.2 | $654k | 123k | 5.30 | |
| Liquidia Corporation Com New | 0.2 | $642k | 17k | 37.74 | |
| Geron Corporation (GERN) | 0.2 | $632k | 424k | 1.49 | |
| Ocuphire Pharma (IRD) | 0.2 | $611k | 134k | 4.55 | |
| Inhibikase Therapeutics Com New (IKT) | 0.2 | $547k | 326k | 1.68 | |
| Context Therapeutics (CNTX) | 0.2 | $500k | 191k | 2.62 | |
| Bright Minds Biosciences Com New (DRUG) | 0.1 | $467k | 6.4k | 72.97 | |
| Voyager Therapeutics (VYGR) | 0.1 | $445k | 115k | 3.86 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $434k | 9.0k | 48.20 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $422k | 4.0k | 105.40 | |
| Prothena Corp SHS (PRTA) | 0.1 | $421k | 43k | 9.72 | |
| Intellia Therapeutics (NTLA) | 0.1 | $404k | 32k | 12.82 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $397k | 333k | 1.19 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $383k | 100k | 3.83 | |
| Palisade Bio (PALI) | 0.1 | $373k | 213k | 1.75 | |
| Monte Rosa Therapeutics (GLUE) | 0.1 | $371k | 23k | 16.45 | |
| Edgewise Therapeutics (EWTX) | 0.1 | $369k | 12k | 31.50 | |
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $367k | 56k | 6.58 | |
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $353k | 27k | 13.06 | |
| Trevi Therapeutics (TRVI) | 0.1 | $324k | 27k | 11.93 | |
| Evolus (EOLS) | 0.1 | $321k | 78k | 4.11 | |
| Nektar Therapeutics Com New (NKTR) | 0.1 | $309k | 4.3k | 71.95 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $292k | 38k | 7.67 | |
| Septerna (SEPN) | 0.1 | $275k | 11k | 24.03 | |
| Ocular Therapeutix (OCUL) | 0.1 | $265k | 31k | 8.47 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $257k | 110k | 2.34 | |
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $232k | 17k | 13.90 | |
| Entera Bio SHS (ENTX) | 0.1 | $228k | 206k | 1.11 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $212k | 2.1k | 102.45 | |
| Beam Therapeutics (BEAM) | 0.1 | $210k | 8.8k | 23.83 | |
| Disc Medicine (IRON) | 0.1 | $207k | 3.2k | 63.94 | |
| Aadi Bioscience (WHWK) | 0.1 | $187k | 54k | 3.45 | |
| Inhibrx Biosciences (INBX) | 0.1 | $167k | 2.5k | 67.23 | |
| Apogee Therapeutics (APGE) | 0.1 | $166k | 2.0k | 84.17 | |
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $150k | 57k | 2.63 | |
| Promis Neurosciences Com Shs (PMN) | 0.0 | $135k | 11k | 12.70 | |
| Tyra Biosciences | 0.0 | $111k | 2.9k | 38.30 | |
| Pepgen (PEPG) | 0.0 | $105k | 60k | 1.77 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $79k | 64k | 1.24 | |
| Macrogenics (MGNX) | 0.0 | $39k | 13k | 2.89 | |
| Cullinan Oncology (CGEM) | 0.0 | $26k | 1.8k | 14.21 |